##fileformat=VCFv4.2
##fileDate=20210205
##reference=ftp://ftp.ncbi.nih.gov/genbank/genomes/Eukaryotes/vertebrates_mammals/Homo_sapiens/GRCh37/special_requests/GRCh37-lite.fa.gz
##source=CIViCpy_v1.1.3
##aboutURL=https://civicdb.org/help/evidence/overview
##INFO=<ID=GN,Number=1,Type=String,Description="HGNC Gene Symbol">
##INFO=<ID=VT,Number=1,Type=String,Description="CIViC Variant Name">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from CIViC. Format: Allele|Consequence|SYMBOL|Entrez Gene ID|Feature_type|Feature|HGVSc|HGVSp|CIViC Variant Name|CIViC Variant ID|CIViC Variant Aliases|CIViC HGVS|Allele Registry ID|ClinVar IDs|CIViC Variant Evidence Score|CIViC Entity Type|CIViC Entity ID|CIViC Entity URL|CIViC Entity Source|CIViC Entity Variant Origin|CIViC Entity Status|CIViC Entity Clinical Significance|CIViC Entity Direction|CIViC Entity Disease|CIViC Entity Drugs|CIViC Entity Drug Interaction Type|CIViC Evidence Phenotypes|CIViC Evidence Level|CIViC Evidence Rating|CIViC Assertion ACMG Codes|CIViC Assertion AMP Category|CIViC Assertion NCCN Guideline|CIVIC Assertion Regulatory Approval|CIVIC Assertion FDA Companion Test ">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	8073509	691	C	A	.	.	GN=ERRFI1;VT=E384*;CSQ=A|loss_of_function_variant&stop_gained|ERRFI1|54206|transcript|ENST00000377482.5|||E384*|691|E384X&GLU384TER|NC\x5F000001\x2E10\x3Ag\x2E8073509C\x3EA|CA338219584|NONE_FOUND|5.0|evidence|1724|https://civicdb.org/links/evidence/1724|24550739_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Erlotinib_(NCIt_ID_C65530)|||C|2|||||
1	11177096	609	C	A	.	.	GN=MTOR;VT=M2327I;CSQ=A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6981G>T||M2327I|609|MET2327ILE|ENST00000361445\x2E4\x3Ac\x2E6981G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11177096C\x3EA|CA338383476|NONE_FOUND|7.0|evidence|1544|https://civicdb.org/links/evidence/1544|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|MTOR_Kinase_Inhibitor_AZD8055_(NCIt_ID_C78856)|||D|4|||||,A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6981G>T||M2327I|609|MET2327ILE|ENST00000361445\x2E4\x3Ac\x2E6981G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11177096C\x3EA|CA338383476|NONE_FOUND|7.0|evidence|1545|https://civicdb.org/links/evidence/1545|27279227_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)&RapaLink-1|Substitutes||D|3|||||
1	11184573	542	G	T	.	.	GN=MTOR;VT=S2215Y;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6644C>A||S2215Y|542|SER2215TYR|ENST00000361445\x2E4\x3Ac\x2E6644C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11184573G\x3ET&NM\x5F004958\x2E3\x3Ac\x2E6644C\x3EA&NP\x5F004949\x2E1\x3Ap\x2ESer2215Tyr|CA16602587|376129|2.0|evidence|1319|https://civicdb.org/links/evidence/1319|24631838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Endometrial_Adenocarcinoma_(DOID_2870)|Sirolimus_(NCIt_ID_C1212)|||D|2|||||
1	11184580	284	G	A	.	.	GN=MTOR;VT=P2213S;CSQ=A|gain_of_function_variant&missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6637C>T||P2213S|284|PRO2213SER|ENST00000361445\x2E4\x3Ac\x2E6637C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11184580G\x3EA&NM\x5F004958\x2E3\x3Ac\x2E6637C\x3ET&NP\x5F004949\x2E1\x3Ap\x2EPro2213Ser|CA16602798|376358|3.0|evidence|722|https://civicdb.org/links/evidence/722|26490311_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|PI3K/BET_Inhibitor_LY294002_(NCIt_ID_C148229)&Capivasertib_(NCIt_ID_C102564)|Combination||D|3|||||
1	11187094	470	G	T	.	.	GN=MTOR;VT=F2108L;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|ENST00000361445\x2E4\x3Ac\x2E6324C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11187094G\x3ET|CA338391533|NONE_FOUND|16.5|evidence|1110|https://civicdb.org/links/evidence/1110|25295501_(PubMed)|Somatic|accepted|Resistance|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Everolimus_(NCIt_ID_C48387)|||C|5|||||,T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|ENST00000361445\x2E4\x3Ac\x2E6324C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11187094G\x3ET|CA338391533|NONE_FOUND|16.5|evidence|1543|https://civicdb.org/links/evidence/1543|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)|||D|4|||||
1	11187796	610	G	A	.	.	GN=MTOR;VT=A2034V;CSQ=A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6101C>T||A2034V|610|ALA2034VAL|ENST00000361445\x2E4\x3Ac\x2E6101C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11187796G\x3EA|CA338393920|NONE_FOUND|8.0|evidence|1547|https://civicdb.org/links/evidence/1547|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)|||D|4|||||,A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6101C>T||A2034V|610|ALA2034VAL|ENST00000361445\x2E4\x3Ac\x2E6101C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11187796G\x3EA|CA338393920|NONE_FOUND|8.0|evidence|1548|https://civicdb.org/links/evidence/1548|27279227_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Breast_Cancer_(DOID_1612)|RapaLink-1&MTOR_Kinase_Inhibitor_AZD8055_(NCIt_ID_C78856)|Substitutes||D|4|||||
1	11188519	283	G	A	.	.	GN=MTOR;VT=H1968Y;CSQ=A|missense_variant&gain_of_function_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.5902C>T||H1968Y|283|HIS1968TYR|ENST00000361445\x2E4\x3Ac\x2E5902C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11188519G\x3EA&NM\x5F004958\x2E3\x3Ac\x2E5902C\x3ET&NP\x5F004949\x2E1\x3Ap\x2EHis1968Tyr|CA16602797|376357|3.0|evidence|713|https://civicdb.org/links/evidence/713|26490311_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Capivasertib_(NCIt_ID_C102564)&PI3K/BET_Inhibitor_LY294002_(NCIt_ID_C148229)|Substitutes||D|3|||||
1	11190804	544	C	T	.	.	GN=MTOR;VT=E1799K;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.5395G>A||E1799K|544|GLU1799LYS&RS863225264|NM\x5F004958\x2E3\x3Ac\x2E5395G\x3EA&NP\x5F004949\x2E1\x3Ap\x2EGlu1799Lys&NC\x5F000001\x2E10\x3Ag\x2E11190804C\x3ET&ENST00000361445\x2E4\x3Ac\x2E5395G\x3EA|CA279594|217823|2.0|evidence|1321|https://civicdb.org/links/evidence/1321|24631838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Clear_Cell_Renal_Cell_Carcinoma_(DOID_4467)|Sirolimus_(NCIt_ID_C1212)|||D|2|||||
1	11217230	543	C	T	.	.	GN=MTOR;VT=C1483Y;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.4448G>A||C1483Y|543|CYS1483TYR|ENST00000361445\x2E4\x3Ac\x2E4448G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11217230C\x3ET&NM\x5F004958\x2E3\x3Ac\x2E4448G\x3EA&NP\x5F004949\x2E1\x3Ap\x2ECys1483Tyr|CA16602888|376453|2.0|evidence|1320|https://civicdb.org/links/evidence/1320|24631838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Sirolimus_(NCIt_ID_C1212)|||D|2|||||
1	11856378	258	G	A	.	.	GN=MTHFR;VT=A222V;CSQ=A|missense_variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|RS1801133&C677T&ALA222VAL|NM\x5F005957\x2E4\x3Ac\x2E665C\x3ET&NP\x5F005948\x2E3\x3Ap\x2EAla222Val&ENST00000376592\x2E1\x3Ac\x2E665G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11856378G\x3EA|CA170990|3520|55.0|evidence|669|https://civicdb.org/links/evidence/669|18704422_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Stomach_Cancer_(DOID_10534)|Fluorouracil_(NCIt_ID_C505)|||B|3|||||,A|missense_variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|RS1801133&C677T&ALA222VAL|NM\x5F005957\x2E4\x3Ac\x2E665C\x3ET&NP\x5F005948\x2E3\x3Ap\x2EAla222Val&ENST00000376592\x2E1\x3Ac\x2E665G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11856378G\x3EA|CA170990|3520|55.0|evidence|1757|https://civicdb.org/links/evidence/1757|26693073_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Rectum_Cancer_(DOID_1993)|Fluorouracil_(NCIt_ID_C505)|||B|4|||||,A|missense_variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|RS1801133&C677T&ALA222VAL|NM\x5F005957\x2E4\x3Ac\x2E665C\x3ET&NP\x5F005948\x2E3\x3Ap\x2EAla222Val&ENST00000376592\x2E1\x3Ac\x2E665G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11856378G\x3EA|CA170990|3520|55.0|evidence|1756|https://civicdb.org/links/evidence/1756|27819322_(PubMed)|Rare_Germline|accepted|Better_Outcome|Supports|Pancreatic_Cancer_(DOID_1793)||||B|4|||||
1	17350521	2411	G	GGCAGCTGGTGCT	.	.	GN=SDHB;VT=p.193_196dupSTSC_(c.577_588dupAGCACCAGCTGC);CSQ=GCAGCTGGTGCT|inframe_insertion|SDHB|6390|transcript|ENST00000375499.3|||p.193_196dupSTSC_(c.577_588dupAGCACCAGCTGC)|2411|C\x2E589\x5F600DUP|NM\x5F003000\x2E2\x3Ac\x2E577\x5F588dupAGCACCAGCTGC&NP\x5F002991\x2E2\x3Ap\x2E193\x5F196dupSTSC&NC\x5F000001\x2E10\x3Ag\x2E17350522\x5F17350533dup|CA658820851||5.0|evidence|6442|https://civicdb.org/links/evidence/6442|20193854_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Paraganglioma_(DOID_0050773)||||C|2|||||
1	27057658	1510	C	T	.	.	GN=ARID1A;VT=Q456*;CSQ=T|stop_gained|ARID1A|8289|transcript|ENST00000324856.7|ENST00000324856.7:c.1366C>T||Q456*|1510|Q73X|ENST00000324856\x2E7\x3Ac\x2E1366C\x3ET|CA339267901|NONE_FOUND|0.0|evidence|4487|https://civicdb.org/links/evidence/4487|27364904_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Clear_Cell_Carcinoma_(DOID_0050934)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||
1	65311203	822	C	A	.	.	GN=JAK1;VT=S703I;CSQ=A|missense_variant|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.2108G>T||S703I|822|SER703ILE|ENST00000342505\x2E4\x3Ac\x2E2108G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E65311203C\x3EA|CA340667333|NONE_FOUND|4.0|evidence|1900|https://civicdb.org/links/evidence/1900|26701727_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Hepatocellular_Carcinoma_(DOID_684)|Ruxolitinib_(NCIt_ID_C77888)|||D|4|||||
1	65311242	1292	C	T	.	.	GN=JAK1;VT=W690*;CSQ=T|stop_gained|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.2069G>A||W690*|1292|TRP690TER&W690X|NC\x5F000001\x2E10\x3Ag\x2E65311242C\x3ET&NC\x5F000001\x2E11\x3Ag\x2E64845559C\x3ET&NM\x5F002227\x2E2\x3Ac\x2E2069G\x3EA&ENST00000342505\x2E4\x3Ac\x2E2069G\x3EA&NP\x5F002218\x2E2\x3Ap\x2ETrp690Ter&ENSP00000343204\x2E4\x3Ap\x2ETrp690Ter|CA340667487|NONE_FOUND|0.0|evidence|2981|https://civicdb.org/links/evidence/2981|27903500_(PubMed)|Somatic|submitted|Resistance|Supports|Colon_Carcinoma_(DOID_1520)|Pembrolizumab_(NCIt_ID_C106432)|||C|4|||||
1	65321333	614	G	A	.	.	GN=JAK1;VT=Q503*;CSQ=A|stop_gained|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.1507C>T||Q503*|614|GLN503TER&Q503X|NC\x5F000001\x2E10\x3Ag\x2E65321333G\x3EA&ENST00000342505\x2E4\x3Ac\x2E1507C\x3ET|CA340669637|NONE_FOUND|10.0|evidence|1567|https://civicdb.org/links/evidence/1567|27433843_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Pembrolizumab_(NCIt_ID_C106432)|||C|4|||||
1	65325837	1291	G	A	.	.	GN=JAK1;VT=P429S;CSQ=A|missense_variant|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.1285C>T||P429S|1291|PRO429SER|ENST00000342505\x2E4\x3Ac\x2E1285C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E65325837G\x3EA|CA340671197|NONE_FOUND|0.0|evidence|2980|https://civicdb.org/links/evidence/2980|27903500_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Pembrolizumab_(NCIt_ID_C106432)|||C|4|||||
1	68152388	705	T	C	.	.	GN=GADD45A;VT=rs681673;CSQ=C|coding_transcript_intron_variant|GADD45A|1647|transcript|ENST00000370986.4|||rs681673|705|1506T\x3EC||CA10728634||15.0|evidence|1751|https://civicdb.org/links/evidence/1751|26422378_(PubMed)|Common_Germline|accepted|Positive|Supports|Ovarian_Cancer_(DOID_2394)||||B|3|||||
1	97915614	737	C	T	.	.	GN=DPYD;VT=DPYD*2A_HOMOZYGOSITY;CSQ=T|splice_donor_variant|DPYD|1806|transcript|ENST00000370192.3|ENST00000370192.3:c.1905+1G>A||DPYD*2A_HOMOZYGOSITY|737|C\x2E1905\x2B1G\x3EA&DPYD\x2A2A&DPYD\x3AIVS14\x20\x2B\x201G\x3EA&RS3918290|NC\x5F000001\x2E10\x3Ag\x2E97915614C\x3ET&NM\x5F000110\x2E3\x3Ac\x2E1905\x2B1G\x3EA&ENST00000370192\x2E3\x3Ac\x2E1905\x2B1G\x3EA|CA114277|432|50.0|evidence|1800|https://civicdb.org/links/evidence/1800|23988873_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Tegafur_(NCIt_ID_C513)&Capecitabine_(NCIt_ID_C1794)&Fluorouracil_(NCIt_ID_C505)|Substitutes||A|5|||||
1	97981343	738	A	C	.	.	GN=DPYD;VT=DPYD*13_HOMOZYGOSITY;CSQ=C|missense_variant|DPYD|1806|transcript|ENST00000370192.3|ENST00000370192.3:c.1679T>G||DPYD*13_HOMOZYGOSITY|738|RS55886062&ILE560SER&I560S|NM\x5F000110\x2E3\x3Ac\x2E1679T\x3EG&NP\x5F000101\x2E2\x3Ap\x2EIle560Ser&ENST00000370192\x2E3\x3Ac\x2E1679T\x3EG&NC\x5F000001\x2E10\x3Ag\x2E97981343A\x3EC|CA228118|88975|50.0|evidence|1801|https://civicdb.org/links/evidence/1801|23988873_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Tegafur_(NCIt_ID_C513)&Capecitabine_(NCIt_ID_C1794)&Fluorouracil_(NCIt_ID_C505)|Substitutes||A|5|||||
1	115256528	893	T	G	.	.	GN=NRAS;VT=Q61H;CSQ=G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.183A>C||Q61H|893|RS121913255&GLN61HIS|NM\x5F002524\x2E4\x3Ac\x2E183A\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGln61His&NC\x5F000001\x2E10\x3Ag\x2E115256528T\x3EG&ENST00000369535\x2E4\x3Ac\x2E183A\x3EC|CA16602358|375871|0.0|evidence|2171|https://civicdb.org/links/evidence/2171|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.183A>C||Q61H|893|RS121913255&GLN61HIS|NM\x5F002524\x2E4\x3Ac\x2E183A\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGln61His&NC\x5F000001\x2E10\x3Ag\x2E115256528T\x3EG&ENST00000369535\x2E4\x3Ac\x2E183A\x3EC|CA16602358|375871|0.0|evidence|2174|https://civicdb.org/links/evidence/2174|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Selumetinib_(NCIt_ID_C66939)|||D|None|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.183A>C||Q61H|893|RS121913255&GLN61HIS|NM\x5F002524\x2E4\x3Ac\x2E183A\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGln61His&NC\x5F000001\x2E10\x3Ag\x2E115256528T\x3EG&ENST00000369535\x2E4\x3Ac\x2E183A\x3EC|CA16602358|375871|0.0|evidence|3690|https://civicdb.org/links/evidence/3690|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|2|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.183A>C||Q61H|893|RS121913255&GLN61HIS|NM\x5F002524\x2E4\x3Ac\x2E183A\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGln61His&NC\x5F000001\x2E10\x3Ag\x2E115256528T\x3EG&ENST00000369535\x2E4\x3Ac\x2E183A\x3EC|CA16602358|375871|0.0|evidence|7332|https://civicdb.org/links/evidence/7332|28341702_(PubMed)|N/A|submitted|Positive|Supports|Malignant_Pleural_Mesothelioma_(DOID_7474)||||D|3|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.183A>C||Q61H|893|RS121913255&GLN61HIS|NM\x5F002524\x2E4\x3Ac\x2E183A\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGln61His&NC\x5F000001\x2E10\x3Ag\x2E115256528T\x3EG&ENST00000369535\x2E4\x3Ac\x2E183A\x3EC|CA16602358|375871|0.0|evidence|7333|https://civicdb.org/links/evidence/7333|26095797_(PubMed)|Unknown|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Ipilimumab_(NCIt_ID_C2654)|||B|4|||||
1	115256529	96	T	C	.	.	GN=NRAS;VT=Q61R;CSQ=C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|23|https://civicdb.org/links/evidence/23|21576590_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Temozolomide_(NCIt_ID_C1244)|||C|2|||||,C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|2186|https://civicdb.org/links/evidence/2186|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|3828|https://civicdb.org/links/evidence/3828|22392911_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|3830|https://civicdb.org/links/evidence/3830|23948972_(PubMed)|Somatic|submitted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|3831|https://civicdb.org/links/evidence/3831|19880792_(PubMed)|Somatic|submitted|Resistance|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|3019|https://civicdb.org/links/evidence/3019|23515407_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Selumetinib_(NCIt_ID_C66939)&Trametinib_(NCIt_ID_C77908)|Substitutes||D|2|||||,C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&ENST00000369535\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|2184|https://civicdb.org/links/evidence/2184|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|2|||||
1	115256529	95	T	A	.	.	GN=NRAS;VT=Q61L;CSQ=A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|NP\x5F002515\x2E1\x3Ap\x2EGln61Leu&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&ENST00000369535\x2E4\x3Ac\x2E182A\x3ET|CA16602361|375874|12.5|evidence|22|https://civicdb.org/links/evidence/22|21576590_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Temozolomide_(NCIt_ID_C1244)|||C|2|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|NP\x5F002515\x2E1\x3Ap\x2EGln61Leu&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&ENST00000369535\x2E4\x3Ac\x2E182A\x3ET|CA16602361|375874|12.5|evidence|2177|https://civicdb.org/links/evidence/2177|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|NP\x5F002515\x2E1\x3Ap\x2EGln61Leu&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&ENST00000369535\x2E4\x3Ac\x2E182A\x3ET|CA16602361|375874|12.5|evidence|2180|https://civicdb.org/links/evidence/2180|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Selumetinib_(NCIt_ID_C66939)|||D|None|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|NP\x5F002515\x2E1\x3Ap\x2EGln61Leu&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&ENST00000369535\x2E4\x3Ac\x2E182A\x3ET|CA16602361|375874|12.5|evidence|3826|https://civicdb.org/links/evidence/3826|20149136_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|NP\x5F002515\x2E1\x3Ap\x2EGln61Leu&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&ENST00000369535\x2E4\x3Ac\x2E182A\x3ET|CA16602361|375874|12.5|evidence|3018|https://civicdb.org/links/evidence/3018|23515407_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Selumetinib_(NCIt_ID_C66939)&Trametinib_(NCIt_ID_C77908)|Substitutes||D|2|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|NP\x5F002515\x2E1\x3Ap\x2EGln61Leu&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&ENST00000369535\x2E4\x3Ac\x2E182A\x3ET|CA16602361|375874|12.5|evidence|2181|https://civicdb.org/links/evidence/2181|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
1	115256530	427	G	T	.	.	GN=NRAS;VT=Q61K;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|1002|https://civicdb.org/links/evidence/1002|26821351_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Everolimus_(NCIt_ID_C48387)&Binimetinib_(NCIt_ID_C84865)|Combination||D|3|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|3833|https://civicdb.org/links/evidence/3833|21107323_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|3834|https://civicdb.org/links/evidence/3834|22392911_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|3836|https://civicdb.org/links/evidence/3836|21107323_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|3837|https://civicdb.org/links/evidence/3837|22395615_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|3838|https://civicdb.org/links/evidence/3838|23948972_(PubMed)|Somatic|submitted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|3839|https://civicdb.org/links/evidence/3839|22773810_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|1474|https://civicdb.org/links/evidence/1474|22194965_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|2907|https://civicdb.org/links/evidence/2907|23515407_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Trametinib_(NCIt_ID_C77908)&Selumetinib_(NCIt_ID_C66939)|Substitutes||D|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|2194|https://civicdb.org/links/evidence/2194|21107323_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||B|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|2196|https://civicdb.org/links/evidence/2196|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|2192|https://civicdb.org/links/evidence/2192|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|3|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|2191|https://civicdb.org/links/evidence/2191|21107323_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|4|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|1475|https://civicdb.org/links/evidence/1475|22194965_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Selumetinib_(NCIt_ID_C66939)|||D|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|7678|https://civicdb.org/links/evidence/7678|25452114_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|2189|https://civicdb.org/links/evidence/2189|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Chemotherapy_(NCIt_ID_C15632)|Combination||C|3|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|8933|https://civicdb.org/links/evidence/8933|30809568_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovary_Serous_Adenocarcinoma_(DOID_5744)|Trametinib_(NCIt_ID_C77908)|||C|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|7172|https://civicdb.org/links/evidence/7172|19954345_(PubMed)|Rare_Germline|submitted|Likely_Pathogenic|Supports|Melanoma_(DOID_1909)||||D|4|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&ENST00000369535\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|24.5|evidence|7169|https://civicdb.org/links/evidence/7169|15899789_(PubMed)|Unknown|submitted|Likely_Pathogenic|Supports|Melanoma_(DOID_1909)||||D|4|||||
1	115258744	93	C	T	.	.	GN=NRAS;VT=G13D;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.38G>A||G13D|93|RS121434596&GLY13ASP|NM\x5F002524\x2E4\x3Ac\x2E38G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly13Asp&NC\x5F000001\x2E10\x3Ag\x2E115258744C\x3ET&ENST00000369535\x2E4\x3Ac\x2E38G\x3EA|CA123620|13901|5.0|evidence|21|https://civicdb.org/links/evidence/21|18375819_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Tanespimycin_(NCIt_ID_C37899)|||C|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.38G>A||G13D|93|RS121434596&GLY13ASP|NM\x5F002524\x2E4\x3Ac\x2E38G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly13Asp&NC\x5F000001\x2E10\x3Ag\x2E115258744C\x3ET&ENST00000369535\x2E4\x3Ac\x2E38G\x3EA|CA123620|13901|5.0|evidence|3840|https://civicdb.org/links/evidence/3840|24553387_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||
1	115258745	895	C	A	.	.	GN=NRAS;VT=G13C;CSQ=A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>T||G13C|895|GLY13CYS&RS121434595|NM\x5F002524\x2E4\x3Ac\x2E37G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGly13Cys&NC\x5F000001\x2E10\x3Ag\x2E115258745C\x3EA&ENST00000369535\x2E4\x3Ac\x2E37G\x3ET|CA16602248|40471|0.0|evidence|2197|https://civicdb.org/links/evidence/2197|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>T||G13C|895|GLY13CYS&RS121434595|NM\x5F002524\x2E4\x3Ac\x2E37G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGly13Cys&NC\x5F000001\x2E10\x3Ag\x2E115258745C\x3EA&ENST00000369535\x2E4\x3Ac\x2E37G\x3ET|CA16602248|40471|0.0|evidence|2200|https://civicdb.org/links/evidence/2200|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Selumetinib_(NCIt_ID_C66939)|||D|None|||||
1	115258745	896	C	G	.	.	GN=NRAS;VT=G13R;CSQ=G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>C||G13R|896|GLY13ARG&RS121434595|NM\x5F002524\x2E4\x3Ac\x2E37G\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGly13Arg&NC\x5F000001\x2E10\x3Ag\x2E115258745C\x3EG&ENST00000369535\x2E4\x3Ac\x2E37G\x3EC|CA151261|13899|2.5|evidence|2203|https://civicdb.org/links/evidence/2203|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>C||G13R|896|GLY13ARG&RS121434595|NM\x5F002524\x2E4\x3Ac\x2E37G\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGly13Arg&NC\x5F000001\x2E10\x3Ag\x2E115258745C\x3EG&ENST00000369535\x2E4\x3Ac\x2E37G\x3EC|CA151261|13899|2.5|evidence|2204|https://civicdb.org/links/evidence/2204|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|1|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>C||G13R|896|GLY13ARG&RS121434595|NM\x5F002524\x2E4\x3Ac\x2E37G\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGly13Arg&NC\x5F000001\x2E10\x3Ag\x2E115258745C\x3EG&ENST00000369535\x2E4\x3Ac\x2E37G\x3EC|CA151261|13899|2.5|evidence|3843|https://civicdb.org/links/evidence/3843|24463458_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,G|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>C||G13R|896|GLY13ARG&RS121434595|NM\x5F002524\x2E4\x3Ac\x2E37G\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGly13Arg&NC\x5F000001\x2E10\x3Ag\x2E115258745C\x3EG&ENST00000369535\x2E4\x3Ac\x2E37G\x3EC|CA151261|13899|2.5|evidence|3842|https://civicdb.org/links/evidence/3842|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|1|||||
1	115258747	878	C	T	.	.	GN=NRAS;VT=G12D;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|NM\x5F002524\x2E4\x3Ac\x2E35G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly12Asp&NC\x5F000001\x2E10\x3Ag\x2E115258747C\x3ET&ENST00000369535\x2E4\x3Ac\x2E35G\x3EA|CA130425|39648|7.5|evidence|3691|https://civicdb.org/links/evidence/3691|24553387_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|NM\x5F002524\x2E4\x3Ac\x2E35G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly12Asp&NC\x5F000001\x2E10\x3Ag\x2E115258747C\x3ET&ENST00000369535\x2E4\x3Ac\x2E35G\x3EA|CA130425|39648|7.5|evidence|3692|https://civicdb.org/links/evidence/3692|22392911_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|NM\x5F002524\x2E4\x3Ac\x2E35G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly12Asp&NC\x5F000001\x2E10\x3Ag\x2E115258747C\x3ET&ENST00000369535\x2E4\x3Ac\x2E35G\x3EA|CA130425|39648|7.5|evidence|1998|https://civicdb.org/links/evidence/1998|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|NM\x5F002524\x2E4\x3Ac\x2E35G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly12Asp&NC\x5F000001\x2E10\x3Ag\x2E115258747C\x3ET&ENST00000369535\x2E4\x3Ac\x2E35G\x3EA|CA130425|39648|7.5|evidence|3693|https://civicdb.org/links/evidence/3693|25666295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|None|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|NM\x5F002524\x2E4\x3Ac\x2E35G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly12Asp&NC\x5F000001\x2E10\x3Ag\x2E115258747C\x3ET&ENST00000369535\x2E4\x3Ac\x2E35G\x3EA|CA130425|39648|7.5|evidence|2002|https://civicdb.org/links/evidence/2002|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
1	115258748	898	C	T	.	.	GN=NRAS;VT=G12S;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.34G>A||G12S|898|RS121913250&GLY12SER|NM\x5F002524\x2E4\x3Ac\x2E34G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly12Ser&NC\x5F000001\x2E10\x3Ag\x2E115258748C\x3ET&ENST00000369535\x2E4\x3Ac\x2E34G\x3EA|CA180753|177778|7.5|evidence|2215|https://civicdb.org/links/evidence/2215|22392911_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)|||D|None|||||
1	115258748	897	C	A	.	.	GN=NRAS;VT=G12C;CSQ=A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.34G>T||G12C|897|GLY12CYS&RS121913250|NM\x5F002524\x2E4\x3Ac\x2E34G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGly12Cys&NC\x5F000001\x2E10\x3Ag\x2E115258748C\x3EA&ENST00000369535\x2E4\x3Ac\x2E34G\x3ET|CA297020|40468|0.0|evidence|3846|https://civicdb.org/links/evidence/3846|24553387_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.34G>T||G12C|897|GLY12CYS&RS121913250|NM\x5F002524\x2E4\x3Ac\x2E34G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGly12Cys&NC\x5F000001\x2E10\x3Ag\x2E115258748C\x3EA&ENST00000369535\x2E4\x3Ac\x2E34G\x3ET|CA297020|40468|0.0|evidence|3845|https://civicdb.org/links/evidence/3845|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Chemotherapy_(NCIt_ID_C15632)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
1	161479745	456	A	G	.	.	GN=FCGR2A;VT=H167R;CSQ=G|missense_variant|FCGR2A|2212|transcript|ENST00000271450.6|ENST00000271450.6:c.500A>G||H167R|456|H166R&HIS167ARG&RS1801274&H131R|NM\x5F001136219\x2E1\x3Ac\x2E500A\x3EG&NP\x5F001129691\x2E1\x3Ap\x2EHis167Arg&ENST00000271450\x2E6\x3Ac\x2E500A\x3EG&NC\x5F000001\x2E10\x3Ag\x2E161479745A\x3EG|CA124361|14823|35.0|evidence|1088|https://civicdb.org/links/evidence/1088|24989892_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Does_Not_Support|Breast_Cancer_(DOID_1612)|Trastuzumab_(NCIt_ID_C1647)|||B|4|||||,G|missense_variant|FCGR2A|2212|transcript|ENST00000271450.6|ENST00000271450.6:c.500A>G||H167R|456|H166R&HIS167ARG&RS1801274&H131R|NM\x5F001136219\x2E1\x3Ac\x2E500A\x3EG&NP\x5F001129691\x2E1\x3Ap\x2EHis167Arg&ENST00000271450\x2E6\x3Ac\x2E500A\x3EG&NC\x5F000001\x2E10\x3Ag\x2E161479745A\x3EG|CA124361|14823|35.0|evidence|1084|https://civicdb.org/links/evidence/1084|22906996_(PubMed)|Common_Germline|accepted|N/A|Does_Not_Support|Breast_Cancer_(DOID_1612)||||B|3|||||
1	161514542	457	A	C	.	.	GN=FCGR3A;VT=F212V;CSQ=C|missense_variant|FCGR3A|2214|transcript|ENST00000367969.3|ENST00000367969.3:c.526T>G||F212V|457|PHE176VAL&V158F&RS396991|NC\x5F000001\x2E10\x3Ag\x2E161514542A\x3EC&NM\x5F001127593\x2E1\x3Ac\x2E526T\x3EG&NP\x5F001121065\x2E1\x3Ap\x2EPhe176Val&ENST00000367969\x2E3\x3Ac\x2E526T\x3EG|CA1211378|225994|35.0|evidence|1087|https://civicdb.org/links/evidence/1087|24989892_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Does_Not_Support|Breast_Cancer_(DOID_1612)|Trastuzumab_(NCIt_ID_C1647)|||B|4|||||,C|missense_variant|FCGR3A|2214|transcript|ENST00000367969.3|ENST00000367969.3:c.526T>G||F212V|457|PHE176VAL&V158F&RS396991|NC\x5F000001\x2E10\x3Ag\x2E161514542A\x3EC&NM\x5F001127593\x2E1\x3Ac\x2E526T\x3EG&NP\x5F001121065\x2E1\x3Ap\x2EPhe176Val&ENST00000367969\x2E3\x3Ac\x2E526T\x3EG|CA1211378|225994|35.0|evidence|1085|https://civicdb.org/links/evidence/1085|22906996_(PubMed)|Common_Germline|accepted|N/A|Does_Not_Support|Breast_Cancer_(DOID_1612)||||B|3|||||
1	161643798	458	T	C	.	.	GN=FCGR2B;VT=I232T;CSQ=C|missense_variant|FCGR2B|2213|transcript|ENST00000358671.5|ENST00000358671.5:c.695T>C||I232T|458|ILE232THR&RS1050501|NM\x5F004001\x2E4\x3Ac\x2E695T\x3EC&NP\x5F003992\x2E3\x3Ap\x2EIle232Thr&ENST00000358671\x2E5\x3Ac\x2E695T\x3EC&NC\x5F000001\x2E10\x3Ag\x2E161643798T\x3EC|CA117549|5467|20.0|evidence|1086|https://civicdb.org/links/evidence/1086|24989892_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|4|||||
1	162724415	139	C	G	.	.	GN=DDR2;VT=L63V;CSQ=G|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.187C>G||L63V|139|LEU63VAL|NM\x5F006182\x2E2\x3Ac\x2E187C\x3EG&NP\x5F006173\x2E2\x3Ap\x2ELeu63Val&ENST00000367922\x2E3\x3Ac\x2E187C\x3EG&NC\x5F000001\x2E10\x3Ag\x2E162724415C\x3EG|CA1217196||4.0|evidence|271|https://civicdb.org/links/evidence/271|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162729630	140	T	G	.	.	GN=DDR2;VT=L239R;CSQ=G|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.716T>G||L239R|140|LEU239ARG|ENST00000367922\x2E3\x3Ac\x2E716T\x3EG&NC\x5F000001\x2E10\x3Ag\x2E162729630T\x3EG|CA16602598|376141|4.0|evidence|270|https://civicdb.org/links/evidence/270|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162729671	141	G	T	.	.	GN=DDR2;VT=G253C;CSQ=T|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.757G>T||G253C|141|GLY253CYS|ENST00000367922\x2E3\x3Ac\x2E757G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E162729671G\x3ET|CA16602599|376142|4.0|evidence|266|https://civicdb.org/links/evidence/266|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162741822	142	G	A	.	.	GN=DDR2;VT=G505S;CSQ=A|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.1513G>A||G505S|142|RS115169993&GLY505SER|NM\x5F006182\x2E2\x3Ac\x2E1513G\x3EA&NP\x5F006173\x2E2\x3Ap\x2EGly505Ser&ENST00000367922\x2E3\x3Ac\x2E1513G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E162741822G\x3EA|CA1217584|282994|4.0|evidence|267|https://civicdb.org/links/evidence/267|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162745497	143	A	T	.	.	GN=DDR2;VT=I638F;CSQ=T|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.1912A>T||I638F|143|ILE638PHE|ENST00000367922\x2E3\x3Ac\x2E1912A\x3ET&NC\x5F000001\x2E10\x3Ag\x2E162745497A\x3ET|CA16602600|376143|4.0|evidence|269|https://civicdb.org/links/evidence/269|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162748390	145	T	A	.	.	GN=DDR2;VT=S768R;CSQ=A|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.2304T>A||S768R|145|SER768ARG|ENST00000367922\x2E3\x3Ac\x2E2304T\x3EA&NC\x5F000001\x2E10\x3Ag\x2E162748390T\x3EA|CA16602365|375878|7.5|evidence|272|https://civicdb.org/links/evidence/272|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Dasatinib_(NCIt_ID_C38713)|Combination||C|3|||||
1	162748407	144	G	T	.	.	GN=DDR2;VT=G774V;CSQ=T|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.2321G>T||G774V|144|GLY774VAL|ENST00000367922\x2E3\x3Ac\x2E2321G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E162748407G\x3ET|CA16602601|376144|4.0|evidence|268|https://civicdb.org/links/evidence/268|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	243859016	1227	C	T	.	.	GN=AKT3;VT=E17K;CSQ=T|missense_variant|AKT3|10000|transcript|ENST00000366539.1|ENST00000366539.1:c.49G>A||E17K|1227|GLU17LYS&RS397514606|NM\x5F001206729\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001193658\x2E1\x3Ap\x2EGlu17Lys&NC\x5F000001\x2E10\x3Ag\x2E243859016C\x3ET&ENST00000366539\x2E1\x3Ac\x2E49G\x3EA|CA130584|39816|3.0|evidence|4521|https://civicdb.org/links/evidence/4521|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||
2	29432664	9	C	T	.	.	GN=ALK;VT=R1275Q;CSQ=T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|48|https://civicdb.org/links/evidence/48|18923525_(PubMed)|Somatic|accepted|Resistance|Supports|Neuroblastoma_(DOID_769)|TAE684|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|39|https://civicdb.org/links/evidence/39|18923525_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|TAE684|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|143|https://civicdb.org/links/evidence/143|22072639_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|2341|https://civicdb.org/links/evidence/2341|22072639_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||B|None|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|1270|https://civicdb.org/links/evidence/1270|23598171_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|1269|https://civicdb.org/links/evidence/1269|23598171_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|1331|https://civicdb.org/links/evidence/1331|26554404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Lorlatinib_(NCIt_ID_C113655)|||D|4|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|2342|https://civicdb.org/links/evidence/2342|21838707_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||B|None|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|7571|https://civicdb.org/links/evidence/7571|18724359_(PubMed)|Rare_Germline|submitted|Pathogenic|Supports|Neuroblastoma_(DOID_769)||||B|5|||||
2	29432682	308	C	G	.	.	GN=ALK;VT=EML4-ALK_G1269A;CSQ=G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|764|https://civicdb.org/links/evidence/764|22235099_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|765|https://civicdb.org/links/evidence/765|23344087_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|4618|https://civicdb.org/links/evidence/4618|23434628_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|4617|https://civicdb.org/links/evidence/4617|23729361_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|4619|https://civicdb.org/links/evidence/4619|24675041_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|4621|https://civicdb.org/links/evidence/4621|27009859_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Large_Cell_Carcinoma_(DOID_4556)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|4620|https://civicdb.org/links/evidence/4620|27045755_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|EML4\x2DALK\x20GLY1269ALA&RS1057519781|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|17.5|evidence|8861|https://civicdb.org/links/evidence/8861|31628085_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ensartinib_(NCIt_ID_C102754)|||B|3|||||
2	29432682	552	C	G	.	.	GN=ALK;VT=ALK_FUSION_G1269A;CSQ=G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|10.0|evidence|1353|https://civicdb.org/links/evidence/1353|25727400_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Brigatinib_(NCIt_ID_C98831)|||D|2|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|10.0|evidence|1354|https://civicdb.org/links/evidence/1354|25727400_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|10.0|evidence|1355|https://civicdb.org/links/evidence/1355|25727400_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Ceritinib_(NCIt_ID_C115112)|||D|2|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala|CA16602590|376132|10.0|evidence|1342|https://civicdb.org/links/evidence/1342|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|3|||||
2	29436859	551	A	C	.	.	GN=ALK;VT=ALK_FUSION_F1245C;CSQ=C|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||ALK_FUSION_F1245C|551|ALK\x20FUSION\x20PHE1245CYS&RS863225283|NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG|CA279597|217856|14.5|evidence|1337|https://civicdb.org/links/evidence/1337|22034911_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Crizotinib_(NCIt_ID_C74061)|||D|2|||||,C|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||ALK_FUSION_F1245C|551|ALK\x20FUSION\x20PHE1245CYS&RS863225283|NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG|CA279597|217856|14.5|evidence|1339|https://civicdb.org/links/evidence/1339|26775591_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,C|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||ALK_FUSION_F1245C|551|ALK\x20FUSION\x20PHE1245CYS&RS863225283|NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG|CA279597|217856|14.5|evidence|1338|https://civicdb.org/links/evidence/1338|26775591_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||C|3|||||
2	29436859	549	A	C	.	.	GN=ALK;VT=F1245C;CSQ=C|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG|CA279597|217856|10.5|evidence|1330|https://civicdb.org/links/evidence/1330|26554404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Lorlatinib_(NCIt_ID_C113655)|||D|3|||||,C|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG|CA279597|217856|10.5|evidence|1333|https://civicdb.org/links/evidence/1333|23598171_(PubMed)|Somatic|accepted|Resistance|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||
2	29436860	1295	A	C	.	.	GN=ALK;VT=F1245V;CSQ=C|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3733T>G||F1245V|1295|RS281864720&PHE1245VAL|NM\x5F004304\x2E4\x3Ac\x2E3733T\x3EG&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Val&NC\x5F000002\x2E11\x3Ag\x2E29436860A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3733T\x3EG|CA345003|65671|7.5|evidence|2987|https://civicdb.org/links/evidence/2987|28183697_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Entrectinib_(NCIt_ID_C114984)|||C|3|||||
2	29443600	172	G	T	.	.	GN=ALK;VT=EML4-ALK_S1206Y;CSQ=T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||EML4-ALK_S1206Y|172|RS1057519782&EML4\x2DALK\x20SER1206TYR|ENST00000389048\x2E3\x3Ac\x2E3617C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443600G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3617C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ESer1206Tyr|CA16602591|376133|6.0|evidence|443|https://civicdb.org/links/evidence/443|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||EML4-ALK_S1206Y|172|RS1057519782&EML4\x2DALK\x20SER1206TYR|ENST00000389048\x2E3\x3Ac\x2E3617C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443600G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3617C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ESer1206Tyr|CA16602591|376133|6.0|evidence|1343|https://civicdb.org/links/evidence/1343|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Ceritinib_(NCIt_ID_C115112)|||D|2|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||EML4-ALK_S1206Y|172|RS1057519782&EML4\x2DALK\x20SER1206TYR|ENST00000389048\x2E3\x3Ac\x2E3617C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443600G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3617C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ESer1206Tyr|CA16602591|376133|6.0|evidence|2865|https://civicdb.org/links/evidence/2865|24670165_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||C|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||EML4-ALK_S1206Y|172|RS1057519782&EML4\x2DALK\x20SER1206TYR|ENST00000389048\x2E3\x3Ac\x2E3617C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443600G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3617C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ESer1206Tyr|CA16602591|376133|6.0|evidence|4622|https://civicdb.org/links/evidence/4622|24675041_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||
2	29443613	171	C	T	.	.	GN=ALK;VT=ALK_FUSION_G1202R;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|1345|https://civicdb.org/links/evidence/1345|24675041_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|441|https://civicdb.org/links/evidence/441|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|1351|https://civicdb.org/links/evidence/1351|25727400_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Brigatinib_(NCIt_ID_C98831)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|1352|https://civicdb.org/links/evidence/1352|22277784_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Tanespimycin_(NCIt_ID_C37899)|||D|2|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|1350|https://civicdb.org/links/evidence/1350|25727400_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|4624|https://civicdb.org/links/evidence/4624|23729361_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|4625|https://civicdb.org/links/evidence/4625|24675041_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|7593|https://civicdb.org/links/evidence/7593|29650534_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Lorlatinib_(NCIt_ID_C113655)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|ALK\x20FUSION\x20GLY1202ARG&RS1057519783|ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg|CA16602592|376134|23.5|evidence|1357|https://civicdb.org/links/evidence/1357|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||
2	29443624	1556	A	G	.	.	GN=ALK;VT=L1198P;CSQ=G|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3593T>C||L1198P|1556|LEU1198PRO|ENST00000389048\x2E3\x3Ac\x2E3593T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29443624A\x3EG&NM\x5F004304\x2E4\x3Ac\x2E3593T\x3EC&NP\x5F004295\x2E2\x3Ap\x2ELeu1198Pro|CA346473047|NONE_FOUND|0.0|evidence|4626|https://civicdb.org/links/evidence/4626|21948233_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||
2	29443625	1275	G	A	.	.	GN=ALK;VT=L1198F;CSQ=A|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3592C>T||L1198F|1275|LEU1198PHE|ENST00000389048\x2E3\x3Ac\x2E3592C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E29443625G\x3EA&NM\x5F004304\x2E4\x3Ac\x2E3592C\x3ET&NP\x5F004295\x2E2\x3Ap\x2ELeu1198Phe|CA346473048|NONE_FOUND|0.0|evidence|4782|https://civicdb.org/links/evidence/4782|26698910_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||
2	29443630	1553	A	T	.	.	GN=ALK;VT=L1196Q;CSQ=T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3587T>A||L1196Q|1553|LEU1196GLN|ENST00000389048\x2E3\x3Ac\x2E3587T\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443630A\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3587T\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Gln|CA346473060|NONE_FOUND|0.0|evidence|4609|https://civicdb.org/links/evidence/4609|23239810_(PubMed)|Somatic|submitted|Resistance|Supports|Anaplastic_Large_Cell_Lymphoma_(DOID_0050744)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||
2	29443631	7	G	T	.	.	GN=ALK;VT=EML4-ALK_L1196M;CSQ=T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4037|https://civicdb.org/links/evidence/4037|21502504_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|442|https://civicdb.org/links/evidence/442|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4035|https://civicdb.org/links/evidence/4035|23434628_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|2343|https://civicdb.org/links/evidence/2343|24670165_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||C|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|7865|https://civicdb.org/links/evidence/7865|31628085_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ensartinib_(NCIt_ID_C102754)|||B|4|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|1341|https://civicdb.org/links/evidence/1341|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|4|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4036|https://civicdb.org/links/evidence/4036|23344087_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4038|https://civicdb.org/links/evidence/4038|21948233_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|7597|https://civicdb.org/links/evidence/7597|29650534_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Alectinib_(NCIt_ID_C101790)&Lorlatinib_(NCIt_ID_C113655)&Brigatinib_(NCIt_ID_C98831)&Ceritinib_(NCIt_ID_C115112)|Substitutes||D|4|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|141|https://civicdb.org/links/evidence/141|21575866_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|237|https://civicdb.org/links/evidence/237|20979473_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4034|https://civicdb.org/links/evidence/4034|22235099_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4039|https://civicdb.org/links/evidence/4039|27565908_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|4040|https://civicdb.org/links/evidence/4040|27507192_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,T|missense_variant&transcript_fusion|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|EML4\x2DALK\x20LEU1196MET&RS1057519784|ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met|CA16602593|376135|21.0|evidence|7598|https://civicdb.org/links/evidence/7598|29650534_(PubMed)|Somatic|submitted|Resistance|Supports|Cancer_(DOID_162)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||